Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bauch

Showing results (591-600 of 610) with videos related to

Pageof 61
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 13, 2006
Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluationQun Li, Tongmei Li, Gui-Dong Zhu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2015
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patientsM Hecht, L Zimmer, C Loquai, et al.
BMC Public Health|March 8, 2022
COVID-19 vaccine perceptions in the initial phases of US vaccine roll-out: an observational study on redditNavin Kumar, Isabel Corpus, Meher Hans, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivativesStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potencyStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.
Journal of Medicinal Chemistry|February 3, 2006
Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivoMichael D Wendt, Wang Shen, Aaron Kunzer, et al.
Journal of Medicinal Chemistry|September 10, 1999
Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacyS J O'Connor, K J Barr, L Wang, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Cancer Research|September 5, 2006
A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivoAlex R Shoemaker, Anatol Oleksijew, Joy Bauch, et al.
Nature Cell Biology|January 27, 2004
A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathwayTewis Bouwmeester, Angela Bauch, Heinz Ruffner, et al.
Pageof 61

Showing results (591-600 of 610) with videos related to

Sort By:
Pageof 61
Bioorganic & Medicinal Chemistry Letters|January 13, 2006
Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluationQun Li, Tongmei Li, Gui-Dong Zhu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2015
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patientsM Hecht, L Zimmer, C Loquai, et al.
BMC Public Health|March 8, 2022
COVID-19 vaccine perceptions in the initial phases of US vaccine roll-out: an observational study on redditNavin Kumar, Isabel Corpus, Meher Hans, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivativesStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potencyStephen L Gwaltney, Stephen J O'Connor, Lissa T J Nelson, et al.
Journal of Medicinal Chemistry|February 3, 2006
Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivoMichael D Wendt, Wang Shen, Aaron Kunzer, et al.
Journal of Medicinal Chemistry|September 10, 1999
Second-generation peptidomimetic inhibitors of protein farnesyltransferase demonstrating improved cellular potency and significant in vivo efficacyS J O'Connor, K J Barr, L Wang, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Cancer Research|September 5, 2006
A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivoAlex R Shoemaker, Anatol Oleksijew, Joy Bauch, et al.
Nature Cell Biology|January 27, 2004
A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathwayTewis Bouwmeester, Angela Bauch, Heinz Ruffner, et al.
Pageof 61